WASHINGTON, Feb 7 (Reuters) - Specialty pharmaceutical company Biodel Inc. said on Wednesday it is planning an initial public offering of as much as $86.25 million in common stock.
WASHINGTON, Feb 7 (Reuters) - Specialty pharmaceutical company Biodel Inc. said on Wednesday it is planning an initial public offering of as much as $86.25 million in common stock.